Trial Profile
Pharmacokinetics and Safety of Ertapenem in the Postpartum Period
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 26 May 2015
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary)
- Indications Bacterial infections; Infections
- Focus Pharmacokinetics
- 22 Jan 2014 Status changed from recruiting to discontinued according to ClinicalTrials.gov record.
- 14 Jun 2013 Planned End Date changed from 1 Dec 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 04 May 2012 New trial record